Back to Awarded Treatment Trials


Awarded Trial: 06T-810

Grant ID

06T-810

Illness

Schizophrenia

Primary Drug/Intervention

L-Stepholidine

Primary Dosage

12.5-200 mg/day

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Terminated

Investigator

Mamo

Sample Size

12

Duration of Study Period for Each Subject

4 weeks

Outcome Measurements

PET

Results

The grant was terminated.

Publication

N/A

Link

N/A

PI Name

David Mamo

Degree

MD

Center

N/A

Institution

Centre for Addiction and Mental Health

Address

250 College Street

City or Town

Toronto

State or Province

Ontario

Zip or Postal Code

M5T 1R8

Country

Canada

Email Address

david_mamo@camh.net